XPC multifaceted roles beyond DNA damage repair: p53-dependent and p53-independent functions of XPC in cell fate decisions
- PMID: 35690409
- DOI: 10.1016/j.mrrev.2021.108400
XPC multifaceted roles beyond DNA damage repair: p53-dependent and p53-independent functions of XPC in cell fate decisions
Abstract
Xeroderma pigmentosum group C protein (XPC) acts as a DNA damage recognition factor for bulky adducts and as an initiator of global genome nucleotide excision repair (GG-NER). Novel insights have shown that the role of XPC is not limited to NER, but is also implicated in DNA damage response (DDR), as well as in cell fate decisions upon stress. Moreover, XPC has a proteolytic role through its interaction with p53 and casp-2S. XPC is also able to determine cellular outcomes through its interaction with downstream proteins, such as p21, ARF, and p16. XPC interactions with effector proteins may drive cells to various fates such as apoptosis, senescence, or tumorigenesis. In this review, we explore XPC's involvement in different molecular pathways in the cell and suggest that XPC can be considered not only as a genomic caretaker and gatekeeper but also as a tumor suppressor and cellular-fate decision maker. These findings envisage that resistance to cell death, induced by DNA-damaging therapeutics, in highly prevalent P53-deficent tumors might be overcome through new therapeutic approaches that aim to activate XPC in these tumors. Moreover, this review encourages care providers to consider XPC status in cancer patients before chemotherapy in order to improve the chances of successful treatment and enhance patients' survival.
Keywords: Cell fate; DNA damage response; DNA repair; Tumor suppressor; XPC; p53.
Copyright © 2021 Elsevier B.V. All rights reserved.
Similar articles
-
Nucleotide excision repair factor XPC enhances DNA damage-induced apoptosis by downregulating the antiapoptotic short isoform of caspase-2.Cancer Res. 2012 Feb 1;72(3):666-75. doi: 10.1158/0008-5472.CAN-11-2774. Epub 2011 Dec 15. Cancer Res. 2012. PMID: 22174370 Free PMC article.
-
p53 responsive nucleotide excision repair gene products p48 and XPC, but not p53, localize to sites of UV-irradiation-induced DNA damage, in vivo.Carcinogenesis. 2003 May;24(5):843-50. doi: 10.1093/carcin/bgg031. Carcinogenesis. 2003. PMID: 12771027
-
Malignant melanoma cells acquire resistance to DNA interstrand cross-linking chemotherapeutics by p53-triggered upregulation of DDB2/XPC-mediated DNA repair.Oncogene. 2014 Apr 10;33(15):1964-74. doi: 10.1038/onc.2013.141. Epub 2013 Apr 22. Oncogene. 2014. PMID: 23604128
-
XPC beyond nucleotide excision repair and skin cancers.Mutat Res Rev Mutat Res. 2019 Oct-Dec;782:108286. doi: 10.1016/j.mrrev.2019.108286. Epub 2019 Jul 8. Mutat Res Rev Mutat Res. 2019. PMID: 31843141 Review.
-
XPC: Going where no DNA damage sensor has gone before.DNA Repair (Amst). 2015 Dec;36:19-27. doi: 10.1016/j.dnarep.2015.09.004. Epub 2015 Sep 9. DNA Repair (Amst). 2015. PMID: 26422135 Free PMC article. Review.
Cited by
-
Targeting p53 pathways: mechanisms, structures, and advances in therapy.Signal Transduct Target Ther. 2023 Mar 1;8(1):92. doi: 10.1038/s41392-023-01347-1. Signal Transduct Target Ther. 2023. PMID: 36859359 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous
